We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

97 hedge funds and large institutions have $127M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 10697 (-9)

11% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 36

32% less capital invested

Capital invested by funds: $185M → $127M (-$58.4M)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
97
Holders Change
-9
Holders Change %
-8.49%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
32
Reduced
36
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
76
Meeder Asset Management
Ohio
$33K +$3.63K +34 +10%
Ameriprise
77
Ameriprise
Minnesota
$30K -$145K -1,359 -79%
Russell Investments Group
78
Russell Investments Group
United Kingdom
$28K -$50.2K -470 -59%
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$25.7K +$107 +1 +0.3%
Bank of Montreal
80
Bank of Montreal
Ontario, Canada
$16K +$3.95K +37 +24%
AIP
81
Ameritas Investment Partners
Nebraska
$13K
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$12K -$1.92K -18 -11%
Lazard Asset Management
83
Lazard Asset Management
New York
$9K +$12K +112 New
Northwestern Mutual Wealth Management
84
Northwestern Mutual Wealth Management
Wisconsin
$6K +$7.58K +71 New
QT
85
Quantamental Technologies
New York
$5K -$2.46K -23 -28%
PAM
86
Panagora Asset Management
Massachusetts
$4K
US Bancorp
87
US Bancorp
Minnesota
$4K
TRCT
88
Tower Research Capital (TRC)
New York
$3K -$12.4K -116 -73%
AG
89
Advisor Group
Arizona
$3K
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$3K
NFG
91
Next Financial Group
Texas
$3K
SPIA
92
Steward Partners Investment Advisory
New York
$3K
JCM
93
Jacobi Capital Management
Pennsylvania
$2K
PNC Financial Services Group
94
PNC Financial Services Group
Pennsylvania
$2K
GRP
95
Global Retirement Partners
California
$1K
WCM
96
Wedge Capital Management
North Carolina
-$1.36M -10,709 Closed
Barclays
97
Barclays
United Kingdom
-$163K -1,278 Closed
MIM
98
MetLife Investment Management
New Jersey
-$128K -1,002 Closed
Connor, Clark & Lunn Investment Management (CC&L)
99
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$109K -854 Closed
MLICM
100
Metropolitan Life Insurance Company (MetLife)
New York
-$91.6K -718 Closed

SRGA Hedge Fund Activity: Q3 2019 in Review

97 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2019, worth a combined $127M — down 32% from $185M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SRGA and 6 opened new positions — a net loss of 9 holders — while 36 trimmed existing stakes and 32 added.

The largest buyer was HealthCor Management, opening a new position worth an estimated $7.68M. The largest seller was Wedge Capital Management, exiting entirely with an estimated $1.36M sold.

  • 97 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2019, down from 106 in Q2 2019.
  • Funds reported $127M of Surgalign Holdings, Inc. Common Stock stock for Q3 2019, down 32% quarter-over-quarter.
  • 6 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2019 and 15 closed out, a net change of -9 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2019 was HealthCor Management, an estimated $7.68M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2019 was Wedge Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q3 2019.